LY-379,268
LY-379,268
LY-379,268 (pronounced L-Y-Three-Seven-Nine-Two-Six-Eight) is a pharmacological agent that is used in scientific research. It is a selective agonist for the metabotropic glutamate receptor group II subtypes mGluR2 and mGluR3.
Etymology
The name LY-379,268 is derived from the naming convention used by the pharmaceutical company Eli Lilly and Company, where "LY" stands for Lilly and the number is a unique identifier for the compound. The exact etymology of the number 379,268 is not publicly disclosed.
Pharmacology
LY-379,268 is a potent and selective agonist for the group II metabotropic glutamate receptors (mGluR2 and mGluR3). It has been used in scientific research to investigate the role of these receptors in various neurological and psychiatric conditions, including schizophrenia, anxiety disorders, and drug addiction.
Related Terms
- Agonist: A substance that initiates a physiological response when combined with a receptor.
- Metabotropic glutamate receptor: A type of glutamate receptor that is active through a metabolic process.
- mGluR2 and mGluR3: Subtypes of the metabotropic glutamate receptor.
- Eli Lilly and Company: The pharmaceutical company that developed LY-379,268.
- Neurological: Pertaining to the nervous system.
- Psychiatric: Pertaining to mental health or the treatment of mental illness.
External links
- Medical encyclopedia article on LY-379,268
- Wikipedia's article - LY-379,268
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski